Multi-analytical Approaches Informing the Risk of Sepsis
- 900 Downloads
Sepsis is a significant cause of mortality and morbidity and is often associated with increased hospital resource utilization, prolonged intensive care unit (ICU) and hospital stay. The economic burden associated with sepsis is huge. With advances in medicine, there are now aggressive goal oriented treatments that can be used to help these patients. If we were able to predict which patients may be at risk for sepsis we could start treatment early and potentially reduce the risk of mortality and morbidity. Analytic methods currently used in clinical research to determine the risk of a patient developing sepsis may be further enhanced by using multi-modal analytic methods that together could be used to provide greater precision. Researchers commonly use univariate and multivariate regressions to develop predictive models. We hypothesized that such models could be enhanced by using multiple analytic methods that together could be used to provide greater insight. In this paper, we analyze data about patients with and without sepsis using a decision tree approach and a cluster analysis approach. A comparison with a regression approach shows strong similarity among variables identified, though not an exact match. We compare the variables identified by the different approaches and draw conclusions about the respective predictive capabilities,while considering their clinical significance.
KeywordsIntensive Care Unit Decision Tree Septic Shock Severe Sepsis Intensive Care Unit Patient
Unable to display preview. Download preview PDF.
- 1.American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 20, 864–874 (1992)Google Scholar
- 2.Alberti, C., Brun-Buisson, C., Burchardi, H., Martin, C., Goodman, S., Artigas, A., Sicignano, A., Palazzo, M., Moreno, R., Boulme, R., Lepage, E., Le Gall, R.: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 28, 108–121 (2002)CrossRefGoogle Scholar
- 4.Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., Dhainaut, J.F., Lopez-Rodriguez, A., Steingrub, J.S., Garber, G.E., Helterbrand, J.D., Ely, E.W., Fisher Jr., C.J.: Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine 344, 699–709 (2001)CrossRefGoogle Scholar
- 5.Brun-Buisson, C., Doyon, F., Carlet, J., Dellamonica, P., Gouin, F., Lepoutre, A., Mercier, J.C., Offenstadt, G., Regnier, B.: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274, 968–974 (1995)CrossRefGoogle Scholar
- 6.Dellinger, R.P., Levy, M.M., Carlet, J.M., Bion, J., Parker, M.M., Jaeschke, R., Reinhart, K., Angus, D.C., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J.F., Gerlach, H., Harvey, M., Marini, J.J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B.T., Townsend, S., Vender, J.S., Zimmerman, J.L., Vincent, J.L.: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Critical Care Medicine 36, 296–327 (2008)Google Scholar
- 10.Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S.M., Vincent, J.L., Ramsay, G.: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 31, 1250–1256 (2003)Google Scholar
- 11.Martin, C., Priestap, F., Fisher, H., Fowler, R.A., Heyland, D.K., Keenan, S.P., Longo, C.J., Morrison, T., Bentley, D., Antman, N.: A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment And Response (STAR) Registry. Critical Care Medicine (in press)Google Scholar
- 12.Minneci, P.C., Deans, K.J., Banks, S.M., Eichacker, P.Q., Natanson, C.: Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann. Intern. Med. 141, 47–56 (2004)Google Scholar
- 13.Pittet, D., Rangel-Frausto, S., Li, N., Tarara, D., Costigan, M., Rempe, L., Jebson, P., Wenzel, R.P.: Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Medicine 21, 302–309 (1995)Google Scholar
- 14.Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., Tomlanovich, M.: Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Med. 345, 1368–1377 (2001)Google Scholar
- 15.Salvo, I., de, C.W., Musicco, M., Langer, M., Piadena, R., Wolfler, A., Montani, C., Magni, E.: The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Medicine 21(suppl. 2), S244–S249 (1995)Google Scholar